CME Group CEO Phupinder Gill announces retirement
Mr. Gill, a 28-year veteran of CME Group, has served in numerous roles during his tenure and was named CEO in 2012.
At the Board's request, Terry Duffy has assumed the expanded role of Chairman and Chief Executive Officer.
The Honorable Terrence A. Duffy has served as Executive Chairman and President of CME Group since 2012.
Previously, he served as Executive Chairman since July 2007.
He served as Chairman of the Board of CME and CME Holdings since April 2002 and as Executive Chairman since October 2006, leading the company through its strategic acquisitions of CBOT and NYMEX as well as CME's initial public offering.
He was Vice Chairman of the Board of CME Holdings Inc. from its formation in August 2001 and of the Board of CME from 1998 to April 2002. He was President of TDA Trading, Inc. from 1981 to 2002.
Mr. Duffy currently serves as Co-Chair of the Mayo Clinic Greater Chicago Leadership Council. He also is Vice Chairman of the CME Group Foundation and President of the CME Group Community Foundation.
Bryan Durkin, who is currently Chief Commercial Officer, has been named President of CME Group.
Mr. Durkin has served as Chief Commercial Officer of CME Group since 2014 and as Chief Operating Officer from 2007-2014. As part of his responsibilities, he led the global company integrations following CME's merger with CBOT in 2007 and NYMEX in 2008.
Mr. Durkin previously held senior leadership roles at CBOT, including Executive Vice President and Chief Operating Officer. He serves on the Board of Directors of CME Europe and Bursa Malaysia Derivatives Berhad.
He is a member of the COMEX Governors Committee, the CFTC's Technology Advisory and Energy and Environmental Markets Advisory Committees. He also serves on the Boards of the CME Group Community Foundation and Misericordia.
During the next two months, Mr. Gill will work with Mr. Duffy and Mr. Durkin and the CME management team on the transition. ■
What to read next
LATEST MOVES FROM Illinois
- Hilco Merchant Resources hires Seth Marks as SVP
- Veltex Corporation appoints Andreas Mauritzson as CEO
- Ingredion Incorporated appoints James P. Zallie as CEO
- Nexgen Packaging appoints Jim Welch as president
- Eton Pharmaceuticals appoints Paul V. Maier to board
More inside POST